article thumbnail

US Publicly-Traded Buyers’ Interest In Acquiring Middle-Market Companies Increases

Benchmark International

Thanks to the new 1% tax now being levied on any publicly traded US companies that buy back their shares, these larger, cash-rich companies have been given a strong incentive to seek acquisition targets.

article thumbnail

GenFlat Inc., Completes Share Exchange Transaction and Becomes Publicly Traded Entity

Global Newswire by Notified: M&A

Completes Share Exchange Transaction and Becomes Publicly Traded Entity. GenFlat Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Able View Completes Business Combination with Hainan Manaslu Acquisition Corp. to Become Publicly Traded Company

Global Newswire by Notified: M&A

Nasdaq: HMAC) (“HMAC”), a publicly traded special purpose acquisition company. The business combination was approved at an extraordinary general meeting of HMAC’s shareholders on August 2, 2023. Upon the closing of the business combination, HMAC and Able View Inc. each becomes a wholly owned subsidiary of Able View Global Inc.

article thumbnail

Court of Chancery Applies Entire Fairness Standard to Conversion of Delaware Corporation to Nevada Corporation

JD Supra: Mergers

TripAdvisor and its controlling corporation, both publicly traded Delaware companies, announced plans to convert to Nevada corporations. Shareholders sued to enjoin the conversions, alleging that the boards of directors had approved the conversions in order to reduce their potential liability in future transactions.

article thumbnail

Mobix Labs, Inc. Closes Business Combination with Chavant Capital Acquisition Corp., Becomes Publicly Traded

Global Newswire by Notified: M&A

- Trading to Commence on Nasdaq Under Ticker Symbol “MOBX” on Friday, December 22, 2023 - - Trading to Commence on Nasdaq Under Ticker Symbol “MOBX” on Friday, December 22, 2023 -

article thumbnail

Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp

Global Newswire by Notified: M&A

Silexion’s first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in.

article thumbnail

Not Done Yet—Employee Benefits Plan Transition and Integration Decisions Continue After M&A Transactions Close

JD Supra: Mergers

He advises private and public companies on designing and implementing nonqualified retirement plans, equity compensation plans, and executive compensation arrangements. He advises public and.

M&A 157